Tina Ventura | Horizon Pharma Plc |
Timothy P. Walbert | Horizon Pharma Plc |
Paul W. Hoelscher | Horizon Pharma Plc |
Shao-Lee Lin | Horizon Pharma Plc |
Vikram Karnani | Horizon Pharma Plc |
Robert F. Carey | Horizon Pharma Plc |
Annabel Eva Samimy | Stifel, Nicolaus & Co., Inc. |
Dana Flanders | Goldman Sachs & Co. LLC |
Gary Nachman | BMO Capital Markets (United States) |
Irina R. Koffler | Mizuho Securities USA LLC |
Ken Cacciatore | Cowen & Co. LLC |
David A. Amsellem | Piper Jaffray & Co. |
Louise Chen | Cantor Fitzgerald Securities |
David R. Risinger | Morgan Stanley & Co. LLC |
David Michael Steinberg | Jefferies LLC |
Good morning, and thank you for standing by. Welcome to the Horizon Pharma plc First Quarter 2018 Earnings Conference Call.
As a reminder, today's conference call is being recorded. I would now like to introduce Ms. Tina Ventura, Senior Vice President of Investor Relations.